Protocol care group for Bronchopulmonary Dysplasia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Christiana Care Health Services, Inc., Newark, DE
Bronchopulmonary Dysplasia+3 More
Protocolized weaning of respiratory support - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this pilot study is to compare if keeping infants on CPAP (continuous positive airway pressure) support for an extended period of time until they are 32 weeks corrected gestational age or 1250 grams (approximately 2 pounds and 12 ounces) will decrease their degree of lung disease as compared to weaning their respiratory support to HFNC (high flow nasal cannula).

Eligible Conditions

  • Infants, Premature
  • Bronchopulmonary Dysplasia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Bronchopulmonary Dysplasia

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: up to 3 months

up to 3 months
Compliance to protocol and balancing measures
Time to reach 2L NC or room air

Trial Safety

Safety Progress

1 of 3

Other trials for Bronchopulmonary Dysplasia

Trial Design

2 Treatment Groups

Usual care group
1 of 2
Protocol care group
1 of 2
Active Control

60 Total Participants · 2 Treatment Groups

Primary Treatment: Protocol care group · No Placebo Group · N/A

Usual care groupNoIntervention Group · 1 Intervention: Usual care group · Intervention Types:
Protocol care group
Other
ActiveComparator Group · 1 Intervention: Protocolized weaning of respiratory support · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 months
Closest Location: Christiana Care Health Services, Inc. · Newark, DE
Photo of delaware 1Photo of delaware 2Photo of delaware 3
2016First Recorded Clinical Trial
1 TrialsResearching Bronchopulmonary Dysplasia
10 CompletedClinical Trials

Who is running the clinical trial?

Christiana Care Health ServicesLead Sponsor
110 Previous Clinical Trials
104,282 Total Patients Enrolled
1 Trials studying Bronchopulmonary Dysplasia
62 Patients Enrolled for Bronchopulmonary Dysplasia
Anastasiya LatushkoPrincipal InvestigatorChristiana Care Health Services, Inc
Kelley Z Kovatis, MDPrincipal InvestigatorChristiana Care Health Services, Inc
3 Previous Clinical Trials
167 Total Patients Enrolled
1 Trials studying Bronchopulmonary Dysplasia
62 Patients Enrolled for Bronchopulmonary Dysplasia

Eligibility Criteria

Age < 18 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.